Page 254 - Small Animal Internal Medicine, 6th Edition
P. 254

226    PART I   Cardiovascular System Disorders



                   BOX 12.2                                      arrhythmias (if present). Other supportive care is given to
                                                                 improve and maintain adequate tissue perfusion, minimize
  VetBooks.ir  Common Clinical Findings in Cats With Systemic    further endothelial damage and blood stasis, optimize organ
                                                                 function, and allow time for collateral circulation develop-
            Arterial Thromboembolism
             Acute limb paresis                                  ment. (Box 12.3). The treatment of CHF in cats is outlined in
                                                                 Chapter 8 and Box 8.1. General supportive care in acute ATE
               Posterior paresis                                 includes active external warming for hypothermia, rotation
               Monoparesis                                       of position and recumbency (if nonambulatory), assistance
               ±Intermittent claudication
             Characteristics of affected limb(s)                 with litter box posturing or bladder expression, and physical
               Painful                                           therapy once the patient is stable.
               Cool distal limbs                                   An analgesic is indicated for cats with ATE, especially for
               Pale footpads                                     the first 24 to 36 hours after the embolic event, because this
               Cyanotic nailbeds                                 is a painful condition. For caudal arterial obstruction, anal-
               Absent arterial pulse                             gesic administration into a more cranial site is recommended
               Contracture of affected muscles (especially       to improve absorption (e.g., IV into the cephalic vein or IM
                  gastrocnemius and cranial tibial)              into the cranial lumbar area). Drugs that are most useful
             Tachypnea/dyspnea                                   include µ-opioids such as fentanyl citrate (IV bolus followed
               Rule out congestive heart failure versus pain or other   by infusion), buprenorphine HCl, hydromorphone, metha-
                  pulmonary disease                              done, oxymorphone, or morphine (see Box 12.3). A fentanyl
             Vocalization (pain and distress)
             Hypothermia                                         patch (25 µg/h size) applied to a shaved area of skin can be
             Anorexia                                            used for pain relief for up to 3 days, but because this formula-
             Lethargy/weakness                                   tion takes about 12 hours to become effective, another anal-
             Signs of heart disease (inconsistent)               gesic is used simultaneously during this initial period.
               Systolic murmur                                   Respiratory depression and reduced gastrointestinal (GI)
               Gallop sounds                                     motility are potential adverse effects of opioids. Narcotics
               Arrhythmias                                       sometimes cause dysphoria in cats. Acepromazine is not rec-
               Cardiomegaly                                      ommended for animals with ATE, despite its vasodilatory
             Signs of congestive heart failure                   α-adrenergic receptor–blocking effects. Improved collateral
               Pulmonary edema                                   flow has not been documented, and hypotension and exac-
               Cavitary effusions                                erbation of dynamic ventricular outflow obstruction (in cats
             Hematologic and biochemical abnormalities
               Azotemia                                          with hypertrophic obstructive cardiomyopathy) are potential
               Increased creatine kinase activity                adverse effects.
               Increased aspartate aminotransferase activity       Antiplatelet therapy is used to inhibit platelet aggregation
               Increased alanine aminotransferase activity       and to  reduce  production of  vasoconstrictive  substances
               Increased lactate dehydrogenase activity          released from activated platelets. Platelet inhibitors are con-
               Increased cardiac biomarkers (Troponin I, NT-proBNP)  sidered especially important for inhibiting thrombus forma-
               Hyperglycemia (stress)                            tion within arteries, where blood flows under high shear
               Lymphopenia (stress)                              rates and platelet adhesion via von Willebrand factor is criti-
               Disseminated intravascular coagulation            cal for clot formation. Clopidogrel (Plavix) has replaced
                                                                 aspirin as the standard of care for antiplatelet therapy in cats
                                                                 with ATE. Clopidogrel is a second-generation thienopyri-
            secondary to widespread muscle injury. Cats with ATE   dine with antiplatelet effects that are more potent than
            usually have normal coagulation parameters (PT and PTT),   aspirin.  A  double-blind  randomized  controlled  trial  in  75
            though fibrinogen and D-dimers might be elevated. Labora-  cats (Feline Arterial Thromboembolism: Clopidogrel versus
            tory tests can reveal abnormalities associated with other   Aspirin Trial; FATCAT) (Hogan, 2015) demonstrated that
            underlying disease as well, such as eosinophilia from HWD.   clopidogrel was superior to aspirin for secondary prevention
            Thyroxine (T 4 ) levels should be measured in older cats to   of ATE and resulted in longer survival times post-ATE.
            screen for hyperthyroidism.                            The thienopyridines inhibit ADP-binding at platelet
              Other causes of acute posterior paresis to be considered   receptors and subsequent ADP-mediated platelet aggrega-
            include  intervertebral disk  disease, spinal  neoplasia  (e.g.,   tion. Clopidogrel irreversibly antagonizes platelet membrane
            lymphoma), trauma, fibrocartilaginous infarction, diabetic   ADP 2Y12  receptors, which inhibit a conformational change of
            neuropathy, and possibly myasthenia gravis.          the GPα IIb   β 3  complex, resulting in reduced binding to
                                                                 fibrinogen  and  von  Willebrand factor.  Clopidogrel also
            Treatment and Prognosis                              impairs platelet release of serotonin, ADP, and other vaso-
            The goals of treatment are to  prevent extension of the   constrictive and platelet-aggregating substances. Clopido-
            embolus and additional thrombus formation, promote   grel’s antiplatelet effects occur after the drug is transformed
            collateral circulation, and manage concurrent CHF and   in the liver to an active metabolite. Similar to humans, there
   249   250   251   252   253   254   255   256   257   258   259